Abeona Therapeutics (ABEO) Operating Income: 2011-2025
Historic Operating Income for Abeona Therapeutics (ABEO) over the last 14 years, with Sep 2025 value amounting to -$24.0 million.
- Abeona Therapeutics' Operating Income fell 56.52% to -$24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$83.2 million, marking a year-over-year decrease of 36.97%. This contributed to the annual value of -$64.2 million for FY2024, which is 36.23% down from last year.
- Abeona Therapeutics' Operating Income amounted to -$24.0 million in Q3 2025, which was down 5.38% from -$22.8 million recorded in Q2 2025.
- Abeona Therapeutics' Operating Income's 5-year high stood at -$8.0 million during Q2 2022, with a 5-year trough of -$46.7 million in Q4 2021.
- Its 3-year average for Operating Income is -$16.2 million, with a median of -$15.3 million in 2024.
- Per our database at Business Quant, Abeona Therapeutics' Operating Income plummeted by 222.18% in 2021 and then skyrocketed by 72.27% in 2022.
- Quarterly analysis of 5 years shows Abeona Therapeutics' Operating Income stood at -$46.7 million in 2021, then spiked by 72.27% to -$12.9 million in 2022, then decreased by 2.11% to -$13.2 million in 2023, then decreased by 26.22% to -$16.7 million in 2024, then crashed by 56.52% to -$24.0 million in 2025.
- Its Operating Income was -$24.0 million in Q3 2025, compared to -$22.8 million in Q2 2025 and -$19.7 million in Q1 2025.